NYSE:GMEDMedical Equipment
Globus Medical (GMED) Stock Leans On Margin Gains As Nevro Recovery Lags
Globus Medical stock barely flinched after earnings, up about 1.6% to US$82.37, yet the quarter was anything but quiet. The musculoskeletal specialist delivered record non‑GAAP earnings per share and a Q2 adjusted EBITDA margin in the mid 30s, a powerful signal of margin strength in a sector where pricing and hospital budgets often squeeze returns.
Investors came into this print with a story centered on long term earnings quality and a relatively modest valuation. This quarter put the focus...